The trial aims to recruit adults with a life expectancy of > 3 months , Eastern Cooperative Oncology Group ( ECOG ) performance status 1 , and : advanced HCC according to the Barcelona criteria ( stage C ) or recurrent HCC after surgical or thermoablative treatment who are not eligible for surgical resection , liver transplantation or thermal ablation ; or two rounds of failed chemoembolisation .